Maternal RSV vaccination and infant nirsevimab immunization found safe and effective

Maternal respiratory syncytial virus (RSV) vaccination and infant nirsevimab immunization, administered alone or sequentially, are safe and effective, according to a study published online May 4 in Pediatrics.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup